AstraZeneca seeks FDA approval for COVID-19 antibody treatment
AstraZeneca has asked the Food and Drug Administration (FDA) to approve its COVID-19 antibody treatment that would act as a long-acting drug mainly for those with compromised immune systems.
Among the first to create a COVID-19 vaccine, the drugmaker said its antibody treatment, AZD7442, is a first of its kind therapy that utilises long-acting antibody protection.
“First and foremost, we want to protect those vulnerable populations that haven’t been adequately protected by the vaccine,” said Menelas Pangaloa, AstraZeneca’s head of Research and Development. “But ultimately, it will be up to health authorities to work out who they choose to immunise.”
According to Mr Pangaloa, the antibody treatment is made for boosting a person’s immunity for up to a year.
He said the current antibody drugs only offer just a month or two of protection. The FDA has already authorised three additional antibody drugs.
“Two of those drugs can be distributed after a person has been exposed to COVID-19 and will help prevent symptoms. AstraZeneca’s drug, on the other hand, would only be given as a preventive measure in addition to a vaccine,” he explained. “On the topic of vaccinations, the FDA has already said that any antibody remedies are not a reason to avoid getting vaccinated. That is because they offer the best level of protection, especially for the long-term.”
According to studies conducted by AstraZeneca, their antibody treatment reduced the chance of developing Covid-19 related symptoms by 77 per cent.
More than three-quarters of the participants in this study were immunocompromised already.
Mr Pangalos added that the drug would provide an additional option to help protect against COVID-19 alongside vaccines.
AstraZeneca also intends to ask for authorisation of their treatment in Europe.
(tca/dpa/NAN)
We have recently deactivated our website's comment provider in favour of other channels of distribution and commentary. We encourage you to join the conversation on our stories via our Facebook, Twitter and other social media pages.
More from Peoples Gazette
Politics
Katsina youths pledge to deliver over 2 million votes to Atiku
“Katsina State is Atiku’s political base because it is his second home.”
Sport
Füllkrug leads Borussia Dortmund 1-0 first-leg win over PSG
The French side improved after the break.
NationWide
COAS salutes troops’ resilience, commitment to war against terrorism
Mr Lagbaja said the troops’ resilience assisted in strengthening the nation’s territorial integrity.
NationWide
Tinubu mourns veteran journalist Sidi Ali
“The late statesman was a prolific writer, publishing 19 books and numerous articles.”
States
Residents scoop fuel as tanker falls in Edo
The truck driver was said to have lost control of the vehicle while trying to ascend the hill.
NationWide
MNJTF working to eliminate Boko Haram, ISWAP in Lake Chad: Official
He urged the public not to panic by the troops’ movements but to offer support to them to eradicate the terrorists.
NationWide
Tinubu congratulates information, interior ministers on birthdays
The President said the minister has brought finesse and immense experience to his role as Nigeria’s image maker.